Life Sciences

Omega Diagnostics Group plc



Transaction type Equity Capital Markets & Corporate Broking

Sector Life Sciences

finnCap have advised Omega Diagnostics Group Plc, the medical diagnostics company focused on allergy, food intolerance and infectious disease, on their £3.6m fundraising & open offer.

Andrew Shepherd, CEO of Omega, commented:

“We are delighted to have received such strong support from both existing and new shareholders for this fundraising. Combined with internally generated cash, the funding will allow the Board to capitalise on opportunities identified across all three of our business segments in order to accelerate the Company’s growth profile and generate future growth in shareholder value.”